Calculated at the exchange rate of RON4.7/EUR, A&D Pharma posted RON4.27 billion revenue last year, which means about 24% decline compared with 2018, when the pharmaceutical wholesale and retail group posted RON5.6 billion revenue, according to Finance Ministry data. There are no data available about the revenue for the companies in the group in 2019 yet.
Sensiblu – the pharmaceutical retail arm, posted RON1.7 billion and the pharmaceutical wholesaler Mediplus posted RON3.8 billion revenue in 2018, according to the Finance Ministry data.
“With an expertise of more than 25 years on the local market, A&D Pharma is one of the largest pharmaceutical groups in Romania, which provides pharmaceutical retail and wholesale services and posted more than EUR900 revenue and had more than 5,000 employees in 2019 (…),” A&D Pharma says in its release.
A&D Pharma was acquired by Czech Republic’s Penta Investments in a deal put at EUR350 milion to EUR400 milion at the end of 2017.
(English version by Loredana Fratila-Cristescu)